Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What CAGR is Anticipated for the Epigenetics Market During the Forecast Period, and Why?

In recent times, the epigenetics market has seen an explosive growth. The market, which is expected to be worth $10.65 billion in 2024, is predicted to surge to $12.83 billion in 2025 with a compound annual growth rate (CAGR) of 20.4%. The significant growth during the historic period can be accredited to the rise in research funding, the mounting incidence of chronic diseases, advances in personalized medicine and cancer research, and an aging population.

In the forthcoming years, the size of the epigenetics market is projected to undergo substantial expansion, reaching a value of $29.08 billion by 2029 with a compound annual growth rate (CAGR) of 22.7%. This expected growth during the forecast period can be accredited to contributions from developments in epigenetic drugs, the impact of epigenetics on environmental health and precision agriculture, regulatory backing, and patient consciousness and advocacy. The forecast period is also expected to witness major trends such as epitranscriptomics, single-cell epigenomics, epigenetic editing, epigenetic biomarkers, research on aging and longevity, as well as microbiome-epigenome interactions.

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the epigenetics Market?

The rising incidences of cancer and other illnesses are playing a vital role in expanding the epigenetics market. As the occurrence of such diseases increases, it naturally causes a surge in the demand for epigenetics. For example, the National Cancer Institute (NCI), a governmental agency based in the US, reported in May 2024 that nearly 20 million new cancer cases were registered in 2022, which led to around 9.7 million deaths attributed to the condition. The predictions suggest that the yearly rate of newly diagnosed cancer cases could rise to 29.9 million by 2040, with deaths due to this disease escalating to 15.3 million. Moreover, data from the Centers for Disease Control and Prevention (CDC) shows that heart disease kills approximately 659,000 individuals annually in the United States. The increasing incidences of cancer and other ailments necessitate examinations and investigations into the specific gene modifications, which will inevitably lead to heightened usage and need for epigenetics. Therefore, the escalating incidences of cancer and other diseases will propel the growth of the epigenetics market in future years.

Request Your Free Epigenetics Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp

Which Companies Are Poised to Shape the Future of the Epigenetics Market?

Major companies operating in the epigenetics market include:

• Illumina Inc._x000D_

• Thermo Fisher Scientific_x000D_

• Merck Millipore_x000D_

• Active Motif_x000D_

• Abcam PLC_x000D_

What Are the Latest Innovations and Trends Influencing the Epigenetics Market?

Top firms in the epigenetics market, such as Illumina Inc., are concentrating their efforts on the creation of technologically superior solutions like DNA sequencing methods. These methods are employed to elevate precision medicine and augment the comprehension and outcomes of disease treatments. DNA sequencing methods allow us to ascertain the sequence of nucleotides in a DNA molecule, thereby unlocking the door to an in-depth genetic investigation. This data holds immense importance in detecting variations in genetics that are associated with diseases and in the progression of precision medicine. For instance, Illumina Inc., an American biotech firm, introduced the Illumina Complete Long Read Technology in March 2023. This technology allows for both long and short read sequencing on a single apparatus, significantly increasing the versatility in genetic research. It requires lesser DNA input and presents a streamlined workflow, making it accessible for challenging samples. This technology also holds a high accuracy rate in variant calling, thereby providing dependable data crucial to a comprehensive genomic analysis.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

Which Industry Segments Are Leading the Development and Expansion of the Epigenetics Market?

The epigenetics market covered in this report is segmented –

1) By Product: Reagents, Enzymes, Instruments, Kits

2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures

3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes

2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases, Other Epigenetic Enzymes

3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers

4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits

What Regions Are Contributing Significantly to the Growth of the Epigenetics Market?

North America was the largest region in the epigenetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

How Is the Scope and Reach of the Epigenetics Market Defined?

Epigenetics is a change in gene activity transmitted to younger cells without modifying the DNA sequence. Epigenetic processes are natural and necessary for many organisms to work, but unusual occurrences can cause disorders, such as various types of cancer, reproductive illnesses, and cardiovascular illnesses. Epigenetics is used detect a type of cancers earlier.

Browse Through More Similar Reports By The Business Research Company:

Tumor Embolization Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

Enzymes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report

Cancer Tumor Profiling Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: